EPITECH GROUP S.p.A. – Trademark Portfolio
Entity Type: 16
EPITECH GROUP S.p.A. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PEAOXA and GLIALIA.
Via Egadi 7
I-20144 Milano
Showing of trademarks Trademarks
Trademark Classifications
EPITECH GROUP S.p.A.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does EPITECH GROUP S.p.A. have?
EPITECH GROUP S.p.A. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does EPITECH GROUP S.p.A. file in?
EPITECH GROUP S.p.A. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are EPITECH GROUP S.p.A.'s most well-known trademarks?
EPITECH GROUP S.p.A.'s registered trademark portfolio includes well-known marks such as PEAOXA and GLIALIA. These are among 2 currently registered trademarks in the portfolio.
What is EPITECH GROUP S.p.A.'s trademark registration success rate?
EPITECH GROUP S.p.A. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.